**Core tip:** Synchronous sporadic bilateral multiple chromophobe renal cell carcinoma (CHRCC) is rare. We present an incidentally detected case of synchronous occurrence of bilateral CHRCC. This case had two concomitant different subtypes of CHRCC in each kidney (classic type and eosinophilic type), accompanied by a clear cell carcinoma and a cyst. The patient underwent retroperitoneal laparoscopic bilateral nephron-sparing surgery and there was no serious postoperative renal dysfunction.

INTRODUCTION
============

Renal cell carcinomas (RCCs) are usually unilateral, but bilateral synchronous or metachronous have been found in 2% to 4% of reported sporadic cases. However, the incidence is higher among patients suffering from hereditary renal cancer such as Von Hippel-Lindau disease, tuberous sclerosis, and Birt-Hogg-Dube syndrome\[[@B1]\]. Synchronous sporadic bilateral multiple chromophobe renal cell carcinoma (CHRCC) is rare.

Surgical excision is considered the standard treatment modality for RCC. In this case report, we describe a case of bilateral simultaneous CHRCC with two histological variants, accompanied by a clear cell carcinoma and a cyst that were all treated by retroperitoneal laparoscopic partial nephrectomy.

CASE PRESENTATION
=================

Chief complaints
----------------

A 50-year-old male patient was admitted to our department because of multiple renal tumors bilaterally, incidentally discovered during abdominal ultrasonography for screening purposes.

History of present illness
--------------------------

The patient had a free previous medical history.

History of past illness
-----------------------

The patient had no previous medical history.

Personal and family history
---------------------------

His family history was unremarkable.

Physical examination
--------------------

The patient's temperature was 36.7°C, heart rate was 78 beats per minute, respiratory rate was 16 breaths per minute, blood pressure was 128/88 mmHg, and oxygen saturation in room air was 96%. Clinical physical examination revealed no abnormalities.

Laboratory examinations
-----------------------

The results of routine blood tests, routine urine tests and urinary sediment examination, routine fecal tests and occult blood test, blood biochemistry, immune indexes, and infection indexes were in the normal range. Electrocardiogram, chest X-ray, and arterial blood gas were also normal. Preoperative blood urea nitrogen (BUN) was 4.4 mmol/L and serum creatinine value was 86 μmol/L. Preoperative glomerular filtration rate (GFR) was 36.2 mL/min in the left kidney and 37.86 mL/min in the right kidney.

Imaging examination
-------------------

To investigate the findings of bilateral renal tumors, the patient underwent contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) examination. Contrast CT/MRI scan showed the following. (1) A 2.0 cm × 1.9 cm × 1.9 cm in size, solid mass at the lower pole of the right kidney, well-defined margins, and exophytic. MRI, T2-weighted image identifying expansile, heterogeneous signal intensity, with a distinct pseudocapsule, heterogeneous delay enhancement,and perirenal fat invasion were not identified. (2) A 1.4 cm × 1.3 cm × 1.1 cm in size, solid mass at the lower pole of the right kidney, with circumscribed enhancing lesions. MRI, T2-weighted image presented a homogeneous intense hyposignal that was considerably less intense than the renal cortex. (3) A 2.2 cm × 1.9 cm × 2.4 cm in size, cyst mass at the upper pole of the right kidney, well-defined margins, and exophytic. And (4) A 3.3 cm × 3.2 cm × 2.9 cm in size, solid mass in the middle of the left kidney, well-defined margins, exophytic, T2-weighted image showing intermediate signal intensity enhanced to the same degree as the renal cortex, slight homogeneous delayed enhancement (Figure [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). There were no abnormally enlarged retroperitoneal lymph nodes, without perinephric tissues or renal vein invasion.

![Computed tomography imaging of the patient. A: Volume representation shows bilateral multiple renal tumors (4 masses); B: Pre-operative axial computed tomography (CT) imaging sections showing a 1.9 cm × 1.9 cm × 2.0 cm tumor arising from the right kidney, exophytic, heterogeneous hypodense, without calcification and hemorrhage, proven to be chromophobe renal cell carcinoma (orange arrow); C: Axial CT imaging sections showing a 3.3 cm × 3.2 cm × 2.9 cm tumor arising from the left kidney, exophytic, homogeneous isodense, without calcification and hemorrhage, proven to be a chromophobe renal cell carcinoma (orange arrow); and D: Axial CT imaging sections showing a 1.4 cm × 1.3 cm × 1.1 cm tumor arising from the right kidney, homogeneous hyperdense, without calcification and hemorrhage, proven to be a clear cell renal cell carcinoma (orange arrow).](WJCC-8-3064-g001){#F1}

![Magnetic resonance imaging of the patient. A: Pre-operative coronal fat-saturated series T2-weighted image of the patient demonstrating a cystic lesion at the upper pole of the right kidney showing strongly signal intensity (long arrow), and a homogeneous low signal intensity, solid mass at right kidney proven to be clear cell renal cell carcinoma (short arrow), and a solid mass, intermediate signal intensity in relation to the adjacent cortex, with a distinct hyposignal pseudocapsule at left kidney proven to be chromophobe renal cell carcinoma (CHRCC) (arrowhead); B: A heterogeneous hypersignal intensity (long arrow) with local cystic, with a distinct hyposignal pseudocapsule (short arrow) on right kidney, proven to be an oncocytic variant of CHRCC; C-E: Axial Contrast-enhanced magnetic resonance image shows heterogeneous signal intensity mass in the right kidney, heterogeneous delayed enhancement, multiple small cysts without enhancement, proven to be an oncocytic variant of CHRCC (short arrow), and a solid mass in the middle of the left kidney, tend to present with progressive uptake in the contrast-enhanced magnetic resonance imaging (MRI), diagnosed as CHRCC (long arrow); F-H: Axial contrast-enhanced MRI shows a solid mass in the right kidney (long arrow), tends to present "fast in and fast out" pattern in contrast-enhanced MRI, and pseudocapsule (short arrow) delayed enhancement, diagnosed as clear cell renal cell carcinoma.](WJCC-8-3064-g002){#F2}

FINAL DIAGNOSIS
===============

There were two different tumors and a cyst (Figure [3](#F3){ref-type="fig"}) on the right kidney. The bigger tumor was diagnosed as oncocytic variant of CHRCC on the lower pole with clear surgical margins. Immunohistochemically, the tumor showed positivity for paired box gene 8 (PAX-8) (+), carbonic anhydrase 7 (CA7)x2 (+), cluster of differentiation (CD117)x2 (+), succinate dehydrogenase iron-sulfur subunit (+), cytokeratin 20 (CK20) (+), but negativity for CAIXx2 (-), vimentin (-), transcription factor binding to IGHM enhancer 3 (TFE3) (-), and alpha-methylacryl-CoA racemase (P504S) (-) (Figure [4](#F4){ref-type="fig"}). The smaller one was diagnosed as clear cell carcinoma with clear surgical margins. Immunohistochemically, the tumor showed positivity for PAX-8 (+), CAIX (+), vimentin (part+), and CK7 (part+), but negativity for mucin 1 (-) and TFE3 (-) (Figure [5](#F5){ref-type="fig"}). The left tumor was diagnosed as CHRCC (classical subtype), with clear surgical margins. In immunocytochemical staining, the tumor cells showed a positive reaction for epithelial membrane antigen (+), CD117 (+), CK7 (part+), and Ki-67 (about 5%+). However, CD10 (-), RCCa (-), vimentin (-), and CAIX (-) were completely negative (Figure [6](#F6){ref-type="fig"}). Bilateral synchronous RCC was diagnosed according to its imaging manifestation and pathological results.

![A 50-year-old male with a pathologically proven cyst in the right kidney. A: H&E staining showed fibromuscular tissue capsule walls without epithelial lining, in which atrophic tubular structures (× 40); B: Simple cyst (× 100).](WJCC-8-3064-g003){#F3}

![A 50-year-old male with a pathologically proven chromophobe renal cell carcinoma in the right kidney (eosinophilic type). A: Hematoxylin and eosin staining showing tubular or acinar structures, eosinophilic to pale cytoplasm with accentuated cell borders, and "raisinoid" nuclear membranes (100 ×); B: Immunohistochemical staining showing negative expression of carbonic anhydrase 9 (100 ×); C: Immunohistochemical staining showing cluster of differentiation 117 was moderately diffusely positive in the cytoplasm/membrane (100 ×); D: Immunohistochemical staining showing cytokeratin 7 (D) was strongly diffusely positive in the cytoplasm/membrane (100 ×).](WJCC-8-3064-g004){#F4}

![A 50-year-old male with pathologically proven clear cell renal cell carcinoma in the right kidney. A: Hematoxylin and eosin staining showing nesting and tubular pattern of growth with eosinophilic cytoplasm in delicate vascular network, clear cytoplasm (100 ×); B: Immunohistochemical staining, carbonic anhydrase 9 was strongly diffusely positive in the cytoplasm/membrane (100 ×); C: Immunohistochemical staining showing negative expression of cluster of differentiation 117 (× 100); D: Immunohistochemical staining showing negative expression of cytokeratin 7 (100 ×).](WJCC-8-3064-g005){#F5}

![A 50-year-old male with pathologically proven chromophobe renal cell carcinoma in the left kidney. A: Hematoxylin and eosin staining showing tumor cells were arranged in solid nests and gland pattern with thick-walled blood vessels, clear cell membrane, reticulated cytoplasm, and "raisinoid" nuclear membranes (100 ×); B: Immunohistochemical staining showing negative expression of carbonic anhydrase 9 (100 ×); C: Cluster of differentiation 117 was moderately diffusely positive in the cytoplasm/membrane (100 ×); D: Cytokeratin 7 was strongly diffusely positive in the cytoplasm/membrane (100 ×).](WJCC-8-3064-g006){#F6}

TREATMENT
=========

The patient was subjected to retroperitoneal laparoscopic nephron-sparing surgery (LNSS) of the right kidney under general anesthesia. There were two different tumors and a cyst on the right kidney. The cyst underwent unroofing. He was discharged on post-operative day 7, without any complications. At 10 wk postoperatively, the patient was readmitted to undergo surgery to remove the tumors of the left kidney. BUN was 3.56 mmol/L and the serum creatinine value was 119.8 mg/dL. GFR was 37.23 mL/min in the left kidney and 18.3 mL/min in right kidney. The patient underwent a second retroperitoneal laparoscopic nephron-sparing surgery under general anesthesia. He was discharged on postoperative day 12.

OUTCOME AND FOLLOW-UP
=====================

Six months postoperatively, there was no recurrence on CT urography. BUN was 5.11 mmol/L and the serum creatinine value was 111.2 μmol/L. There was no evidence of recurrence or lymphadenopathy at 12 mo after surgery. He was continuously followed up.

DISCUSSION
==========

The incidence of bilateral RCC is relatively low, accounting for 1%-5% of all renal cancers\[[@B2],[@B3]\]. Typical symptoms are abdominal pain, gross hematuria, and palpable mass, but most bilateral RCC has no symptoms. There was no difference in manifestation between bilateral multiple RCC and single RCC. As a screening tool, ultrasonography plays an important role in the detection of kidney tumors. Our case was first detected by ultrasonography. Whether there is a family history, bilateral RCC is divided into sporadic and hereditary. Bilateral RCC can occur synchronously or metachronously. Bilateral synchronous RCC accounts for 3.0%-4.2% of RCC, and metachronously bilateral RCC accounts for 0.4% of RCC\[[@B4]\].

At present, the etiology and pathogenesis of bilateral synchronous RCC are still unclear, especially for those with different histological subtypes. Synchronous tumors may arise from similar embryologic processes affected by abnormal factors such as carcinogens and hormones. Cancer stem cells that follow a dissimilar differentiation pathway regulated by tissue microenvironmental interactions might lead to different renal tumors\[[@B5]\]. In the published literature, the rate of pathologic concordance of sporadic synchronous bilateral RCC ranged from 84% to 95%, and the surveillance epidemiology and end results revealed a histology concordance rate of 93%, and nuclear grade concordance was 85%\[[@B6]\].

To date, the origin of bilateral RCC has not been definitively established. As limited studies on the genetics of bilateral tumors exist, defining the clinical behavior of these lesions remains important\[[@B7]\]. According to the literature, the synchronous presentation of RCC of diverse histology is a rare phenomenon. CCRCC and papillary renal cell carcinoma (PRCC) are the main histologic subtypes in bilateral RCC\[[@B8],[@B9]\]. To the best of our knowledge, only six cases of synchronous bilateral CHRCC were reported by searching PubMed\[[@B10]-[@B15]\]. Tsutsumi et al\[[@B10]\] reported "Multiple chromophobe renal cell carcinoma: A case report" in 2010. The patient underwent left partial nephrectomy, and all of the excised tumors were determined to be CHRCC. Hidai et al\[[@B11]\] reported a case of a 42-year-old male with bilateral chromophobe cell RCC diagnosed with tuberous sclerosis complex and polycystic kidney disease in 1997. Yakout et al\[[@B12]\] reported a case of "synchronous bilateral chromophobe renal cell carcinoma" in a 71-year-old female in 2001. Mukai et al\[[@B13]\] reported "Synchronous bilateral chromophobe renal cell carcinoma: A case report" in 2009. Radopoulos et al\[[@B14]\] reported a case of a 57-year-old male patient with two bilateral synchronous chromophobe RCCs accompanied by an oncocytoma and an angiomyolipoma. The patient was treated with open partial nephrectomy. Li et al\[[@B15]\] reported a case of "synchronous bilateral multiple chromophobe renal cell carcinoma complicated with right renal cysts" in 2012. In our case, the patient had bilateral simultaneous CHRCC with two histological variants (classic type and eosinophilic type), accompanied by clear cell renal cell carcinoma (CCRCC) and a cyst. This suggests that both renal tumors may be primary, and further proves that there are different pathological types of bilateral renal tumors in the same body.

Most bilateral RCC has no typical symptoms in the early phase, and is usually discovered incidentally. CT and MRI remain the most widely available and effective modality for the detection and staging of RCC. It is quite important to accurately diagnose and distinguish RCC before surgery, especially bilateral RCC. Recently, some studies have demonstrated that imaging methods can differentiate CCRCC from the papillary and chromophobe histological types, which are the second and third most common RCC types, respectively\[[@B16]\]. CCRCC usually presents with intense contrast uptake in the corticomedullary phase and typical washout in the nephrographic phase. PRCC and CHRCC appear hypovascular compared with the adjacent renal parenchyma. These tumors tend to present with progressive uptake in contrast-enhanced CT/MRI\[[@B17],[@B18]\], with maximum enhancement occurring during the renal parenchyma phase\[[@B19]\]. CHRCC is less intense than the CCRCC, and more intense than PRCC. Most CHRCC tends to be more homogeneous than CCRCC on CT/MRI, and CHRCC can exhibit a central scar and segmental enhancement inversion in some cases. CT/MRI findings correlate closely with the histopathology characteristics. The stellate scar observed on imaging corresponds to the coalescent central bands of fibrosis and compressed blood vessels that have been described as histologic findings in CHRCC\[[@B20]\]. In addition, microscopic lipid, calcification, necrosis and hemorrhage are uncommon. A central stellate scar appears to be an exclusive feature of CHRCC, although it may also be found in oncocytoma, because they originate from a common progenitor cell in the kidney and have overlapping histologic features\[[@B21],[@B22]\]. However, histologic examination remains necessary to determine if a lesion is CHRCC or oncocytoma.

CHRCC originates from intercalated cells of the collecting duct system. CHRCC is a rare neoplasm that is less aggressive and has the best prognosis among RCCs. CHRCC tends to be solid, well-defined lesions. It is a heterogeneous group including classic type, eosinophilic type, and mixed type\[[@B23]\]. The simultaneous occurrence of the two subtypes of CHRCC is rare. This case had two concomitant different subtypes of CHRCC in each kidney (classic type and eosinophilic type), accompanied by a CCRCC.

Surgery, whether nephron-sparing or radical nephrectomy, is considered to be the ideal treatment for RCC. However, the choice of simultaneous or staged surgery is still controversial\[[@B24]\]. The surgical approach is determined by performance status and comorbidity of the patient, and tumor characteristics (size, location, and growth pattern). Balancing the complete eradication of potentially malignant tissue with minimizing treatment-related loss of renal function is challenging. Staging surgery can determine the histological type and related risk factors of the primary tumor in a timely manner, providing a reference point for management of the secondary contralateral renal tumor and renal reserve for possible secondary interventions. Nephron-sparing surgery is the treatment standard for patients with bilateral RCCs\[[@B25]\]. Our patient was treated with retroperitoneal LNSS. The malignancy of CHRCC is lower than that of CCRCC with less metastasis. In combination with imaging data, to ensure that one kidney was working normally during the two surgeries and to reduce the risk of perioperative acute renal failure, our case underwent right LNSS followed by left LNSS. Compared with open surgery, LNSS has advantages of less operative time, decreased blood loss, shorter ischemia time, and fewer complications, but it has a higher technical requirement for surgeons. These advantages are more fully reflected in the treatment of bilateral RCC. The interval time for the two surgeries was 10 wk. The patients still recovered and were discharged smoothly after two major operations.

Prior studies have reported a statistically significantly decreased 5-year survival rate in patients with bilateral RCC compared to patients with unilateral RCC\[[@B26],[@B27]\]. However, recent studies have demonstrated that the prognosis of patients with bilateral RCC is similar to that of patients with unilateral RCC\[[@B2],[@B28],[@B29]\]. Treatment timing, surgical options, and individual differences may contribute to these differences. Follow-up in patients at regular intervals is necessary to exclude local recurrence and systemic progression, and should include physical examination, chest X ray, CT, and GFR based on the blood test of kidney function. The case was followed up without obvious signs of tumor recurrence and metastasis.

CONCLUSION
==========

This was a rare case of bilateral simultaneous CHRCC with two histological variants, accompanied by a CCRCC and a cyst. Balancing complete eradication of potentially malignant tissue with minimizing treatment-related loss of renal function is a challenge. Our case report may serve as a reference for further studies.
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